Literature DB >> 34408375

Tongue Spindle Cell Rhabdomyosarcoma: A Rare Case Report and Literature Review.

Ursula M Jariod-Ferrer1, Miguel Angel Trigo-Cebrian2, Bianca Pantilie1, María V Simon Sanz1, Leire Esparza Lasaga1, Marina A Gavin-Clavero1, Elena Delso-Gil1, Javier Martinez-Trufero3.   

Abstract

Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm with its origin in the skeletal muscle and is extremely rare in adults. By the World Health Organization (WHO), a new variant of RMS has been classified, i.e. the spindle cell (Sc) and sclerosing (S) RMS. While the Sc-RMS shows intersecting fascicles of nonpleomorphic spindle cells, the S-RMS is characterized by a marked hyalinization in a pseudovascular growth pattern associated with round-to-spindled tumour cells. According to the analysed data, the Sc/S-RMS variant has a worse outcome than other variants. The new classification of the Sc/S-RMS variant is valuable to the clinical practice. There are not many oral Sc/S-RMS cases reported. The aim of this paper is to demonstrate that an early diagnosis, an adequate treatment and a multidisciplinary approach have a positive effect on the prognosis of the patient. In this study, we analyse a new case of Sc-RMS variant in a young adult with an early diagnosis and a favourable outcome as a result of an appropriated multidisciplinary treatment: early surgery, radiotherapy and chemotherapy treatment. © The Association of Oral and Maxillofacial Surgeons of India 2020.

Entities:  

Keywords:  Oral cancer; Rhabdomyosarcoma; Sarcoma; Spindle cell rhabdomyosarcoma

Year:  2020        PMID: 34408375      PMCID: PMC8313614          DOI: 10.1007/s12663-020-01447-3

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  21 in total

1.  Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.

Authors:  Judith A Punyko; Ann C Mertens; K Scott Baker; Kirsten K Ness; Leslie L Robison; James G Gurney
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 2.  Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.

Authors:  Suman Malempati; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

Review 3.  Sclerosing rhabdomyosarcoma: report of a case arising in the head and neck of an adult and review of the literature.

Authors:  Julie C Robinson; Mary S Richardson; Brad W Neville; Terrence A Day; Angela C Chi
Journal:  Head Neck Pathol       Date:  2012-09-19

4.  Rhabdomyosarcoma, Spindle Cell/Sclerosing Variant: A Clinical and Histopathological Examination of this Rare Variant with Three New Cases from the Oral Cavity.

Authors:  Molly Housley Smith; Daniel Atherton; John D Reith; Nadim M Islam; Indraneel Bhattacharyya; Donald M Cohen
Journal:  Head Neck Pathol       Date:  2017-05-02

5.  Adult rhabdomyosarcoma: outcome following multimodality treatment.

Authors:  Darren J Little; Matthew T Ballo; Gunar K Zagars; Peter W T Pisters; Shreyaskumar R Patel; Adel K El-Naggar; Adam S Garden; Robert S Benjamin
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

Review 6.  Orofacial rhabdomyosarcoma: report of a case and review of the literature.

Authors:  Manuel A Gordón-Núñez; Marta R Piva; Edvaldo D Dos Anjos; Roseana A Freitas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2008-12-01

7.  Spindle cell rhabdomyosarcoma of the tongue in an infant: a case report with emphasis on differential diagnosis of childhood spindle cell lesions.

Authors:  Anita Gupta; John Maddalozzo; Thanda Win Htin; Anil Shah; Pauline M Chou
Journal:  Pathol Res Pract       Date:  2004       Impact factor: 3.250

8.  Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.

Authors:  Andrew L Folpe; Jesse K McKenney; Julia A Bridge; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

9.  Clinico-epidemiological analysis of orofacial rhabdomyosarcoma in a Nigerian population.

Authors:  O A Fatusi; S O Ajike; S O Olateju; A T Adebayo; O O Gbolahan; S A Ogunmuyiwa
Journal:  Int J Oral Maxillofac Surg       Date:  2009-01-18       Impact factor: 2.789

10.  The Third Intergroup Rhabdomyosarcoma Study.

Authors:  W Crist; E A Gehan; A H Ragab; P S Dickman; S S Donaldson; C Fryer; D Hammond; D M Hays; J Herrmann; R Heyn
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.